Results 281 to 290 of about 96,603 (330)

Clinical effectiveness analysis of transurethral vaporization prostatectomy for benign prostatic hyperplasia. [PDF]

Medicine (Baltimore)
Cheng C, Wang L, Yang T, Liao Y, Yan Y, Lu K.   +5 more
europepmc   +1 more source

Health Benefits and Therapeutic Potential of Quercetin

Journal of Food Biochemistry, Volume 2026, Issue 1, 2026.
Quercetin, a polyphenolic compound prevalent in many fruits, vegetables, and other dietary sources, has attracted considerable interest due to its extensive health benefits. This review examines its diverse biological properties, particularly its antioxidant and anti‐inflammatory effects. The study integrates recent scientific findings to elucidate the
Mahendra Aryal, Kim Wei Chan
wiley   +1 more source

Negative impact of benign prostatic hyperplasia on fertility in dogs-a mini-review. [PDF]

Front Vet Sci
Domosławska-Wyderska A, Zduńczyk S, Rafalska A.   +2 more
europepmc   +1 more source

HYPOPLASTIC EFFECT OF PROSTOWIN VATI AND VASTIKARMA IN THE MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA

, 2013
Arun Kumar Singh, Akhlesh Kr. Bhargava, H.K. Kushwaha   +2 more
openalex   +1 more source

Reliability of Negative Prostate MRI for Biopsy Decision‐Making in the Male Han Chinese Population

Prostate Cancer, Volume 2026, Issue 1, 2026.
Background Multiparametric magnetic resonance imaging (mpMRI) has been widely utilized in clinical practice for identifying clinically significant prostate cancer (csPCa). Although mpMRI demonstrates a pooled negative predictive value (NPV) of 90%, additional clinical parameters require evaluation to enhance this metric specifically for the Chinese ...
Fangming Wang, Yan Zhang, Meng Fu, Yuzhe Tang, Haifeng Song, Gang Zhang, Boxing Su, Jianxing Li, Hendrik Van Poppel   +8 more
wiley   +1 more source

Benign prostatic hyperplasia and risk of urological cancers: a prospective cohort study based on the UK biobank. [PDF]

Discov Oncol
Guo J, Zhou L, He J, Pan X, Liu D, Li J, Zhou Q, Wang L.   +7 more
europepmc   +1 more source

Tyrer–Cuzick Lifetime Risk Is Not Associated With Non‐BRCA1/2 Pathogenic Variants for Breast Carcinoma

The Breast Journal, Volume 2026, Issue 1, 2026.
Background The Tyrer–Cuzick (TC) or IBIS risk calculator is a widely used tool to estimate the probability of developing breast cancer. The latest version incorporates various factors to assess the risk of breast cancer, including family history, personal history, breast density, and past medical history.
Divya Rao, Chloe Wernecke, Lisa Baron, Steven Cai, Peter Beitsch, Rakesh Patel, Pat Whitworth, Barry Rosen, Nhan Nguyen Tran, Kevin Hughes, Paul L. Baron, Imtiaz Wani   +11 more
wiley   +1 more source

Comparative Effectiveness and Safety of Finasteride and Dutasteride in the Treatment of Benign Prostatic Hyperplasia: A Real-World Retrospective Study. [PDF]

Medicina (Kaunas)
Ratajski J, Ciechan K, Jędrzejczyk P, Kaminski TW, Uciechowski P, Ząbkowski T.   +5 more
europepmc   +1 more source

Bond Urology Group: Faculty of Health Sciences and Medicine [PDF]

, 2012
Chess-Williams, Russ
core  

Stromal Steroid 5 Alpha-Reductase 2 Promotes Prostate Growth through WNT5A–Lymphoid Enhancer–Binding Factor 1–Insulin-Like Growth Factor 1 Signaling in Benign Prostatic Hyperplasia

Christina Sharkey, Boqing Gu, Xingbo Long, Yaoliang Tang, Nicolas Patsatzis, Steven Li, Aria F. Olumi, Zongwei Wang   +7 more
openalex   +2 more sources